Three-Statement Breakdown
REVENUE UP
Revenue rose 9.1% year over year to $14.7B, and carried a 13.8% net margin.
REVENUE
+9.1%
14,669
GROSS PROFIT
—
—
NET INCOME
+4.2%
2,018
EPS (DILUTED)
-0.6%
$3.42
| Income statement | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | YoY | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
|
11,537 | 11,529 | 11,526 | 13,431 | 15,310 | 14,206 | 13,441 | 14,669 | +9.1% |
| Cost of revenue |
NOT DISCLOSED
|
(3,854) | — | — | — | — | — | — | — | — |
| Gross profit |
NOT DISCLOSED
|
7,683 | — | — | — | — | — | — | — | — |
| Operating income |
|
1,965 | 2,104 | 2,116 | 2,203 | 2,428 | 2,481 | 2,386 | 2,583 | +8.3% |
| Interest expense |
|
(700) | (773) | (840) | (842) | (953) | (1,055) | (1,255) | (1,468) | +17.0% |
| Income tax |
|
(181) | (128) | -6 | -70 | -135 | -146 | -402 | -245 | — |
| Net income |
|
1,261 | 1,372 | 1,473 | 1,597 | 1,736 | 1,771 | 1,936 | 2,018 | +4.2% |
| EPS (diluted) |
|
$2.47 | $2.64 | $2.79 | $2.96 | $3.17 | $3.21 | $3.44 | $3.42 | -0.6% |
Click a line to select it — Enter or the EXPAND pill folds out its quarter-by-quarter history.
No comparable bridge for this view yet.
↹ CLICK A LINE TO SELECT · ⌘F FIND LINE ITEM
SRC 10-Q FILED 2026-07-30 ↗